메뉴 건너뛰기




Volumn 77, Issue 3, 2006, Pages 333-337

Patient knowledge regarding tardive dyskinesia;Patientenwissen über tardive dyskinesien

Author keywords

Adverse event; Antipsychotic drugs; Informed consent; Patient information; Schizophrenia; Tardive dyskinesia

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT;

EID: 33645225282     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-005-1897-6     Document Type: Article
Times cited : (3)

References (22)
  • 1
    • 0030008987 scopus 로고    scopus 로고
    • Consent to neuroleptic medication for schizophrenia: Clinical, ethical and legal issues
    • Brabbins C, Butler J, Bentall R (1996) Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues. Br J Psychiatry 168:540-544
    • (1996) Br J Psychiatry , vol.168 , pp. 540-544
    • Brabbins, C.1    Butler, J.2    Bentall, R.3
  • 2
    • 0342927486 scopus 로고    scopus 로고
    • Decisional capacity for informed consent in schizophrenia research
    • Carpenter WT Jr, Gold JM, Lahti AC et al. (2000) Decisional capacity for informed consent in schizophrenia research. Arch Gen Psychiatry 57:533-538
    • (2000) Arch Gen Psychiatry , vol.57 , pp. 533-538
    • Carpenter Jr., W.T.1    Gold, J.M.2    Lahti, A.C.3
  • 3
    • 0036203368 scopus 로고    scopus 로고
    • Informing patients about tardive dyskinesia: Four-year follow up of a trial of patient education
    • Chaplin R, Timehin C (2002) Informing patients about tardive dyskinesia: four-year follow up of a trial of patient education. Aust N Z J Psychiatry 36:99-103
    • (2002) Aust N Z J Psychiatry , vol.36 , pp. 99-103
    • Chaplin, R.1    Timehin, C.2
  • 4
    • 0031890873 scopus 로고    scopus 로고
    • Informing patients about tardive dyskinesia. Controlled trial of patient education
    • Chaplin R, Kent A (1998) Informing patients about tardive dyskinesia. Controlled trial of patient education. Br J Psychiatry 172:78-81
    • (1998) Br J Psychiatry , vol.172 , pp. 78-81
    • Chaplin, R.1    Kent, A.2
  • 5
    • 1542373740 scopus 로고    scopus 로고
    • Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
    • Correll CU, Leucht S, Kane JM (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161:414-425
    • (2004) Am J Psychiatry , vol.161 , pp. 414-425
    • Correll, C.U.1    Leucht, S.2    Kane, J.M.3
  • 6
    • 0023769457 scopus 로고
    • Legal aspects of tardive dyskinesia
    • Davis JM, Comaty J (1988) Legal aspects of tardive dyskinesia. Encephale 14:257-261
    • (1988) Encephale , vol.14 , pp. 257-261
    • Davis, J.M.1    Comaty, J.2
  • 7
    • 0030012977 scopus 로고    scopus 로고
    • What role do patients wish to play in treatment decision making?
    • Deber RB, Kraetschmer N, Irvine J (1996) What role do patients wish to play in treatment decision making? Arch Intern Med 156:1414-1420
    • (1996) Arch Intern Med , vol.156 , pp. 1414-1420
    • Deber, R.B.1    Kraetschmer, N.2    Irvine, J.3
  • 8
    • 0018993657 scopus 로고
    • A study of the capacity of schizophrenic patients to give informed consent
    • Grossman L, Summers F (1980) A study of the capacity of schizophrenic patients to give informed consent. Hosp Community Psychiatry 31:205-206
    • (1980) Hosp Community Psychiatry , vol.31 , pp. 205-206
    • Grossman, L.1    Summers, F.2
  • 9
    • 0025803516 scopus 로고
    • Aufklärung über Späthyperkinesen
    • Helmchen H (1991) Aufklärung über Späthyperkinesen. Nervenarzt 62:265-268
    • (1991) Nervenarzt , vol.62 , pp. 265-268
    • Helmchen, H.1
  • 10
    • 0030639627 scopus 로고    scopus 로고
    • Einwilligung nach Aufklärung ("informed consent") in der Psychiatrie - Europäische Standards und Unterschiede, Probleme und Empfehlungen
    • Helmchen H (1997) Einwilligung nach Aufklärung ("informed consent") in der Psychiatrie - Europäische Standards und Unterschiede, Probleme und Empfehlungen. Fortschr Neurol Psychiatr 65:23-33
    • (1997) Fortschr Neurol Psychiatr , vol.65 , pp. 23-33
    • Helmchen, H.1
  • 11
    • 0022376420 scopus 로고
    • Psychotic patients' understanding of informed consent
    • Irwin M, Lovitz A, Marder SR (1985) Psychotic patients' understanding of informed consent. Am J Psychiatry 142:1351-1354
    • (1985) Am J Psychiatry , vol.142 , pp. 1351-1354
    • Irwin, M.1    Lovitz, A.2    Marder, S.R.3
  • 12
    • 0019469049 scopus 로고
    • Informed consent: Recall about tardive dyskinesia
    • Jaffe R (1981) Informed consent: recall about tardive dyskinesia. Compr Psychiatry 22:434-437
    • (1981) Compr Psychiatry , vol.22 , pp. 434-437
    • Jaffe, R.1
  • 13
    • 3042785965 scopus 로고    scopus 로고
    • Tardive dyskinesia rates with atypical antipsychotics in adults: Prevalence and incidence
    • Kane JM (2004) Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 65(Suppl 9):16-20
    • (2004) J Clin Psychiatry , vol.65 , Issue.9 SUPPL. , pp. 16-20
    • Kane, J.M.1
  • 15
    • 0027139231 scopus 로고
    • Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication
    • Kleinman I, Schachter D, Jeffries J et al. (1993) Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication. Hosp Community Psychiatry 44:1189-1191
    • (1993) Hosp Community Psychiatry , vol.44 , pp. 1189-1191
    • Kleinman, I.1    Schachter, D.2    Jeffries, J.3
  • 16
    • 0022414828 scopus 로고
    • Informing patients about tardive dyskinesia
    • Munetz MR, Roth LH (1985) Informing patients about tardive dyskinesia. Arch Gen Psychiatry 42:866-871
    • (1985) Arch Gen Psychiatry , vol.42 , pp. 866-871
    • Munetz, M.R.1    Roth, L.H.2
  • 17
    • 0021949502 scopus 로고
    • Overcoming resistance to talking to patients about tardive dyskinesia
    • Munetz MR (1985) Overcoming resistance to talking to patients about tardive dyskinesia. Hosp Community Psychiatry 36:283-287
    • (1985) Hosp Community Psychiatry , vol.36 , pp. 283-287
    • Munetz, M.R.1
  • 18
    • 0036238035 scopus 로고    scopus 로고
    • Informed consent and the capacity for voluntarism
    • Roberts LW (2002) Informed consent and the capacity for voluntarism. Am J Psychiatry 159:705-712
    • (2002) Am J Psychiatry , vol.159 , pp. 705-712
    • Roberts, L.W.1
  • 19
    • 1542442346 scopus 로고    scopus 로고
    • Evaluation of patient knowledge regarding oral anticoagulants
    • Roche-Nagle G, Chambers F, Nanra J et al. (2003) Evaluation of patient knowledge regarding oral anticoagulants. Ir Med J 96:211-213
    • (2003) Ir Med J , vol.96 , pp. 211-213
    • Roche-Nagle, G.1    Chambers, F.2    Nanra, J.3
  • 20
    • 0020771337 scopus 로고
    • Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date?
    • Roth LH (1983) Is it best to obtain informed consent from schizophrenic patients about the possible risk of drug treatment, for example, tardive dyskinesia, before initiating treatment or at a later date? J Clin Psychopharmacol 3:207-208
    • (1983) J Clin Psychopharmacol , vol.3 , pp. 207-208
    • Roth, L.H.1
  • 21
    • 0028308547 scopus 로고
    • The effect of psychopathology on the ability of schizophrenic patients to give informed consent
    • Schachter D, Kleinman I, Prendergast P et al. (1994) The effect of psychopathology on the ability of schizophrenic patients to give informed consent. J Nerv Ment Dis 182:360-362
    • (1994) J Nerv Ment Dis , vol.182 , pp. 360-362
    • Schachter, D.1    Kleinman, I.2    Prendergast, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.